Understanding estimated glomerular filtration rate: Implications for identifying chronic kidney disease

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

PURPOSE OF REVIEW: Glomerular filtration rate (GFR) can be estimated using serum markers such as serum creatinine (SCr) or cystatin C. This review presents new insights into estimated GFR based on theory, validation studies, SCr assay standardization, cystatin C, and longitudinal comparison with measured GFR. RECENT FINDINGS: The estimation of GFR by SCr differs in health and in chronic kidney disease (CKD) due to differences in GFR range and in creatinine production between these two populations. Among populations with normal baseline GFR, there is a more rapid decline in measured GFR than in SCr-based estimated GFR. While elevated SCr is specific for CKD, other disease processes may lead to elevated cystatin C. Validation is improved by refitting equation coefficients to compare populations, recognizing the asymmetry between estimated GFR and measured GFR, and using residual plots instead of Bland-Altman plots to assess bias. SUMMARY: As a screening test, SCr should be interpreted as a marker of CKD probability in the context of the patient's clinical presentation. Measured GFR or creatinine clearance may be helpful in high-risk patients with normal SCr levels. GFR estimating equations should be reserved for patients with identified CKD. Standardized SCr and cystatin C assays are needed.

Original languageEnglish (US)
Pages (from-to)242-249
Number of pages8
JournalCurrent Opinion in Nephrology and Hypertension
Volume16
Issue number3
DOIs
StatePublished - May 2007

Fingerprint

Glomerular Filtration Rate
Chronic Renal Insufficiency
Creatinine
Cystatin C
Serum
Population
Validation Studies
Biomarkers

Keywords

  • Cystatin C
  • Estimating equations
  • Glomerular filtration rate
  • Serum creatinine

ASJC Scopus subject areas

  • Nephrology
  • Internal Medicine

Cite this

@article{20fdd292fbf74835877a709c55a0a524,
title = "Understanding estimated glomerular filtration rate: Implications for identifying chronic kidney disease",
abstract = "PURPOSE OF REVIEW: Glomerular filtration rate (GFR) can be estimated using serum markers such as serum creatinine (SCr) or cystatin C. This review presents new insights into estimated GFR based on theory, validation studies, SCr assay standardization, cystatin C, and longitudinal comparison with measured GFR. RECENT FINDINGS: The estimation of GFR by SCr differs in health and in chronic kidney disease (CKD) due to differences in GFR range and in creatinine production between these two populations. Among populations with normal baseline GFR, there is a more rapid decline in measured GFR than in SCr-based estimated GFR. While elevated SCr is specific for CKD, other disease processes may lead to elevated cystatin C. Validation is improved by refitting equation coefficients to compare populations, recognizing the asymmetry between estimated GFR and measured GFR, and using residual plots instead of Bland-Altman plots to assess bias. SUMMARY: As a screening test, SCr should be interpreted as a marker of CKD probability in the context of the patient's clinical presentation. Measured GFR or creatinine clearance may be helpful in high-risk patients with normal SCr levels. GFR estimating equations should be reserved for patients with identified CKD. Standardized SCr and cystatin C assays are needed.",
keywords = "Cystatin C, Estimating equations, Glomerular filtration rate, Serum creatinine",
author = "Rule, {Andrew D}",
year = "2007",
month = "5",
doi = "10.1097/MNH.0b013e328057de8b",
language = "English (US)",
volume = "16",
pages = "242--249",
journal = "Current Opinion in Nephrology and Hypertension",
issn = "1062-4821",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Understanding estimated glomerular filtration rate

T2 - Implications for identifying chronic kidney disease

AU - Rule, Andrew D

PY - 2007/5

Y1 - 2007/5

N2 - PURPOSE OF REVIEW: Glomerular filtration rate (GFR) can be estimated using serum markers such as serum creatinine (SCr) or cystatin C. This review presents new insights into estimated GFR based on theory, validation studies, SCr assay standardization, cystatin C, and longitudinal comparison with measured GFR. RECENT FINDINGS: The estimation of GFR by SCr differs in health and in chronic kidney disease (CKD) due to differences in GFR range and in creatinine production between these two populations. Among populations with normal baseline GFR, there is a more rapid decline in measured GFR than in SCr-based estimated GFR. While elevated SCr is specific for CKD, other disease processes may lead to elevated cystatin C. Validation is improved by refitting equation coefficients to compare populations, recognizing the asymmetry between estimated GFR and measured GFR, and using residual plots instead of Bland-Altman plots to assess bias. SUMMARY: As a screening test, SCr should be interpreted as a marker of CKD probability in the context of the patient's clinical presentation. Measured GFR or creatinine clearance may be helpful in high-risk patients with normal SCr levels. GFR estimating equations should be reserved for patients with identified CKD. Standardized SCr and cystatin C assays are needed.

AB - PURPOSE OF REVIEW: Glomerular filtration rate (GFR) can be estimated using serum markers such as serum creatinine (SCr) or cystatin C. This review presents new insights into estimated GFR based on theory, validation studies, SCr assay standardization, cystatin C, and longitudinal comparison with measured GFR. RECENT FINDINGS: The estimation of GFR by SCr differs in health and in chronic kidney disease (CKD) due to differences in GFR range and in creatinine production between these two populations. Among populations with normal baseline GFR, there is a more rapid decline in measured GFR than in SCr-based estimated GFR. While elevated SCr is specific for CKD, other disease processes may lead to elevated cystatin C. Validation is improved by refitting equation coefficients to compare populations, recognizing the asymmetry between estimated GFR and measured GFR, and using residual plots instead of Bland-Altman plots to assess bias. SUMMARY: As a screening test, SCr should be interpreted as a marker of CKD probability in the context of the patient's clinical presentation. Measured GFR or creatinine clearance may be helpful in high-risk patients with normal SCr levels. GFR estimating equations should be reserved for patients with identified CKD. Standardized SCr and cystatin C assays are needed.

KW - Cystatin C

KW - Estimating equations

KW - Glomerular filtration rate

KW - Serum creatinine

UR - http://www.scopus.com/inward/record.url?scp=34247240950&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247240950&partnerID=8YFLogxK

U2 - 10.1097/MNH.0b013e328057de8b

DO - 10.1097/MNH.0b013e328057de8b

M3 - Article

C2 - 17420668

AN - SCOPUS:34247240950

VL - 16

SP - 242

EP - 249

JO - Current Opinion in Nephrology and Hypertension

JF - Current Opinion in Nephrology and Hypertension

SN - 1062-4821

IS - 3

ER -